- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/08 - Bridged systems
Patent holdings for IPC class C07D 471/08
Total number of patents in this class: 2004
10-year publication summary
|
124
|
113
|
130
|
134
|
142
|
131
|
143
|
157
|
131
|
124
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4826 |
66 |
| Merck Sharp & Dohme LLC | 3732 |
57 |
| Wockhardt Limited | 215 |
48 |
| Boehringer Ingelheim International GmbH | 4636 |
41 |
| Purdue Pharma L.P. | 496 |
39 |
| Neurosearch A/S | 169 |
35 |
| Meiji Seika Pharma Co., Ltd. | 254 |
34 |
| Novartis AG | 10612 |
33 |
| Gilead Sciences, Inc. | 2106 |
28 |
| Skyhawk Therapeutics, Inc. | 120 |
26 |
| Nippon Chemiphar Co., Ltd. | 235 |
24 |
| Janssen Pharmaceutica N.V. | 3358 |
22 |
| Achillion Pharmaceuticals, Inc. | 164 |
22 |
| Vertex Pharmaceuticals Incorporated | 1630 |
21 |
| Takeda Pharmaceutical Company Limited | 2721 |
19 |
| Hoffmann-La Roche Inc. | 3546 |
18 |
| Pfizer Inc. | 3401 |
17 |
| Merck Patent GmbH | 5752 |
17 |
| Centre National de La Recherche Scientifique | 10706 |
17 |
| Rigel Pharmaceuticals, Inc. | 530 |
17 |
| Other owners | 1403 |